WS #16622

Global equity markets are undergoing a severe risk-off rotation, with the Nasdaq 100 plunging 3.6%—its worst daily decline since June 5—driven by a collapse in semiconductor valuations and a broader reassessment of AI capital expenditure. Intel has become the epicenter of this sell-off, cratering nearly 30% on disastrous Q4 guidance, dragging down the entire chip sector (AMD, AVGO, MRVL) and signaling that the AI infrastructure build-out may be facing margin destruction or demand saturation. This tech wreck is fueling a defensive rotation into biopharmaceuticals, where Eli Lilly and other large drugmakers are hitting record highs as investors flee high-multiple growth stocks. Simultaneously, geopolitical tensions in the Middle East are escalating, with Iran utilizing limpet mines to attack tankers in the Strait of Hormuz. This supply shock is driving oil prices toward $120 and European natural gas up 5%, creating a hostile macro environment for airlines and shipping. While the Fed remains hawkish with Musalem signaling further hikes, the market is pricing in a recessionary shock rather than a soft landing, evidenced by the flight to safety in bonds and the collapse of speculative tech assets. The convergence of a tech earnings collapse and an energy supply crisis is creating a 'double-whammy' for the S&P 500, which is down 1.6%.